Arteris, Inc. (NASDAQ:AIP) CEO Sells $141,941.80 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 14,180 shares of Arteris stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $10.01, for a total value of $141,941.80. Following the completion of the transaction, the chief executive officer now directly owns 10,207,746 shares of the company’s stock, valued at approximately $102,179,537.46. This trade represents a 0.14 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

K Charles Janac also recently made the following trade(s):

• On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total value of $180,702.72.
• On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total value of $10,656.36.
• On Wednesday, October 2nd, K Charles Janac sold 5,520 shares of Arteris stock. The shares were sold at an average price of $7.18, for a total transaction of $39,633.60.

Arteris Trading Up 5.9 %

Shares of Arteris stock opened at $9.48 on Friday. The stock has a market capitalization of $380.88 million, a PE ratio of -9.87 and a beta of 1.25. Arteris, Inc. has a 52 week low of $4.83 and a 52 week high of $10.60. The stock has a 50 day moving average price of $8.22 and a two-hundred day moving average price of $7.88. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16.

Institutional Trading of Arteris

Hedge funds have recently bought and sold shares of the business. US Bancorp DE bought a new position in shares of Arteris in the third quarter valued at $34,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Arteris in the second quarter worth approximately $86,000. Algert Global LLC bought a new position in Arteris during the 2nd quarter valued at $115,000. MetLife Investment Management LLC boosted its holdings in Arteris by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Arteris in the 3rd quarter worth $226,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Rosenblatt Securities reissued a “buy” rating and set a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.